Asymmetry Capital Management, L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$727,000
-56.2%
39,273
-42.2%
1.56%
-43.8%
Q1 2019$1,660,000
+107.2%
67,909
+120.0%
2.77%
+25.4%
Q4 2018$801,000
-54.7%
30,861
-44.7%
2.21%
+35.5%
Q3 2018$1,768,000
-31.6%
55,847
-16.0%
1.63%
-35.7%
Q2 2018$2,583,000
+21.0%
66,488
-14.0%
2.54%
-4.9%
Q1 2018$2,135,000
+18.9%
77,346
-22.0%
2.67%
+9.6%
Q4 2017$1,795,000
+76.5%
99,181
+57.5%
2.44%
+106.6%
Q3 2017$1,017,00062,9621.18%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders